No Data
No Data
Express News | Lixte Biotechnology Provides Update on Recent Activities and Developments
LIXTE Biotechnology Holdings to Present at Two Investor Conferences
10-Q: Q2 2024 Earnings Report
Express News | Lixte Biotechnology Holdings Announces Collaboration on a New Colon Cancer Clinical Trial
Express News | LIXTE Biotechnology Announces Collaboration With Roche And Netherlands Cancer Institute For Clinical Trial On LB-100's Effectiveness In Enhancing Immune Recognition Of Colon Cancer Cells In MSI Low Metastatic Colon Cancer
Express News | Lixte Biotechnology Holdings to Collaborate With Roche and Netherlands Cancer Institute in New Colon Cancer Clinical Trial
No Data